EHA Abstracts 2019

May 16, 2019

Upcoming presentations at EHA:

The HORIZON data will be presented as an oral presentation by Professor Paul G. Richardson, in the session “Novel strategies in multiple myeloma” on June 16 at 08.45 (CET) in the auditorium. Paul G. Richardson, MD, is Professor of Medicine at Harvard Medical School and Clinical Program Leader, Director of Clinical Research at the Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute in Boston, Massachusetts, USA.

The posters will made public presented on Friday, June 14 at 09.30 and presented between 17.30 – 19.00 (CET).

Oncopeptides will also host a symposium at EHA on June 13th between 18.45 – 20.45 (CET) at the Amsterdam RAI Hall 3B, under the title “Challenging the Treatment Paradigm in Multiple Myeloma”

The four abstracts in the EHA Abstract book:

HORIZON (OP-106): Updated efficacy and safety of melflufen in relapsed / refractory multiple myeloma (RRMM) patients refractory to daratumumab (DARA) and/or pomalidomide (POM)
Topic: Myeloma and other monoclonal gammopathies – Clinical
Session Title: Novel strategies in multiple myeloma
Abstract Code – S 1605

ANCHOR (OP-104): A phase 1/2 study update of melflufen and dexamethasone plus bortezomib or daratumumab in in relapsed / refractory multiple myeloma patients refractory to an IMiD or a proteasome inhibitor
Topic: Myeloma and other monoclonal gammopathies – Clinical
Session Title: Myeloma and other monoclonal gammopathies – Clinical
Abstract Code – 608

O-12-M1: An evaluation of time to next treatment in melflufen and dexamethasone treated patients with relapsed / refractory multiple myeloma
Topic: Myeloma and other monoclonal gammopathies – Clinical
Session Title: Myeloma and other monoclonal gammopathies – Clinical
Abstract Code – PF 628

Tolerability of treatments for relapsed / refractory multiple myeloma: A systematic review
Topic: Quality of life, palliative & supportive care, ethics and health economics
Session Title: Quality of life, palliative & supportive care, ethics and health economics
Abstract Code – PF 726